Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Capital Expenditures

Nymox Pharm Corp Capital Expenditures Chart (NYMX)

Nymox Pharm Corp annual/quarterly Capital Expenditures from 2010 to 2018.
  • Nymox Pharm Corp Capital Expenditures for the quarter ending December 12, 2018 was $0m a 100.00% decrease of 0m year over year
  • Nymox Pharm Corp Capital Expenditures for the last 12 months ending September 09, 2019 was $0m a -44.00% increase of 0m year over year
  • Nymox Pharm Corp Annual Capital Expenditures for 2018 was $0m a 94.44% decrease of 0m from 2017
  • Nymox Pharm Corp Annual Capital Expenditures for 2016 was $0m a -76.40% increase of 0m from 2015
  • Nymox Pharm Corp Annual Capital Expenditures for 2014 was $0m a -84.38% increase of 0m from 2013
Other Cash Flow Metrics:
  • Nymox Pharm Corp Cash Flow from Operations for the quarter ending September 09, 2018 was $-2m a 46.48% decrease of -1m year over year
  • Nymox Pharm Corp Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-1m a 97.41% decrease of -1m year over year
  • Nymox Pharm Corp Total Revenue for the quarter ending September 09, 2018 was $0m a -163.24% decrease of 0m year over year
View Chart On Koyfin

Quarterly NYMX Capital Expenditures Data

12/2018$0m
09/2018$0m
12/2016$0m
12/2014$0m
09/2014$0m
06/2014$0m
03/2014$0m
12/2013$0m
09/2013$0m
06/2013$0m

Annual NYMX Capital Expenditures Data

2018$0m
2016$0m
2014$0m
2013$0m
2012$0m
2011$0m
2010$0m